Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2015 Filed Apr 2, 2015 14:46 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 140 | $71.07 | $9,949.80 |
DisclosureSEC source: 0000059478-15-000122 · wf-form4_142798597987755.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,179 Read SEC document |
| March 31, 2015 Filed Jan 25, 2016 20:48 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000245 · wf-form5_145375492583852.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,017 Read SEC document |
| March 30, 2015 Filed Mar 31, 2015 17:43 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 180,000 | $73.94 | $13,308,660.00 |
DisclosureSEC source: 0001209191-15-030360 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,035,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.84 to $74.08, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 16:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,100 | $77.39 | $781,628.90 |
DisclosureSEC source: 0001209191-15-028701 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,215,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.355 to $77.43, inclusive. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 16:50 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 179,900 | $76.95 | $13,842,405.50 |
DisclosureSEC source: 0001209191-15-028701 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,225,904 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.36 to $77.35, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 12, 2015 Filed Apr 30, 2015 17:28 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 1,580 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000126 · wf-form4_143041487471156.xml · nonDerivative · entry 5 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,201 Read SEC document |
| March 11, 2015 Filed Apr 30, 2015 17:28 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 3,675 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000126 · wf-form4_143041487471156.xml · nonDerivative · entry 4 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,781 Read SEC document |
| March 10, 2015 Filed Apr 30, 2015 17:28 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 10,654 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000126 · wf-form4_143041487471156.xml · nonDerivative · entry 3 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,456 Read SEC document |
| March 09, 2015 Filed Mar 10, 2015 20:56 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 4,000 | $69.27 | $277,080.00 |
DisclosureSEC source: 0000059478-15-000117 · wf-form4_142602099886745.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,690 F1 · price: This transaction was executed in multiple trades at prices ranging from $69.22 to $69.34. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Since the date of the reporting person's last ownership report, he transferred 3,920 shares of common stock to his ex-wife pursuant to a domestic relations order. Read SEC document |
| March 04, 2015 Filed Jan 25, 2016 20:39 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
GiftCommon Stock | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000241 · wf-form5_145375438646216.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,588 Read SEC document |
| February 27, 2015 Filed Mar 2, 2015 21:18 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 139 | $71.56 | $9,946.84 |
DisclosureSEC source: 0000059478-15-000115 · wf-form4_142533110671697.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,851 Read SEC document |
| February 11, 2015 Filed Feb 12, 2015 21:53 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 9,036 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-15-000089 · wf-form4_142377800130815.xml · derivative · entry 6 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,036 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2015 Filed Feb 12, 2015 21:53 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Tax withholdingCommon Stock | 8,065 | $70.50 | $568,582.50 |
DisclosureSEC source: 0000059478-15-000089 · wf-form4_142377800130815.xml · nonDerivative · entry 2 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,728 Read SEC document |
| February 11, 2015 Filed Feb 12, 2015 21:53 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Exercise / conversionCommon Stock | 9,036 | $56.18 | $507,642.48 |
DisclosureSEC source: 0000059478-15-000089 · wf-form4_142377800130815.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2015 Filed May 7, 2015 19:07 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 55,061 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000136 · wf-form4_143102561614503.xml · nonDerivative · entry 6 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 333,324 F2 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| February 10, 2015 Filed May 7, 2015 19:07 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 55,061 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000136 · wf-form4_143102561614503.xml · nonDerivative · entry 5 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Read SEC document |
| February 05, 2015 Filed Feb 6, 2015 14:57 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 374 | $71.03 | $26,565.22 |
DisclosureSEC source: 0000059478-15-000074 · wf-form4_142323463472456.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,046 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 15:00 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 5,316 | $70.00 | $372,120.00 |
DisclosureSEC source: 0000059478-15-000076 · wf-form4_142323480541939.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,061 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2014. F2 · price: This transaction was executed in multiple trades at prices ranging from $69.85 to $70.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 15:03 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
SaleCommon Stock | 11,085 | $70.08 | $776,836.80 |
DisclosureSEC source: 0000059478-15-000078 · wf-form4_142323500599128.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,420 F1 · price: This transaction was executed in multiple trades at prices ranging from $70.01 to $70.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 15:06 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,147 | $69.99 | $220,258.53 |
DisclosureSEC source: 0000059478-15-000080 · wf-form4_142323520866384.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,138 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2014. F2 · price: This transaction was executed in multiple trades at prices ranging from $69.80 to $70.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 03, 2015 Filed Feb 3, 2015 20:59 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
SaleCommon Stock | 71,711 | $70.72 | $5,071,401.92 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · nonDerivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,505 F2 · price: This transaction was executed in multiple trades at prices ranging from $70.50 to $71.13. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 02, 2015 Filed Feb 3, 2015 20:59 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
SaleCommon Stock | 50,000 | $70.87 | $3,543,500.00 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · nonDerivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,216 F1 · price: This transaction was executed in multiple trades at prices ranging from $70.74 to $71.01. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 02, 2015 Filed Feb 3, 2015 21:06 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 10,068 | $71.84 | $723,285.12 |
DisclosureSEC source: 0000059478-15-000064 · wf-form4_142299759301402.xml · nonDerivative · entry 3 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,377 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2014. F2 · price: This transaction was executed in multiple trades at prices ranging from $71.64 to $71.96. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 02, 2015 Filed Feb 3, 2015 21:08 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 4,769 | $71.51 | $341,031.19 |
DisclosureSEC source: 0000059478-15-000066 · wf-form4_142299772208656.xml · nonDerivative · entry 3 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,285 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2014. F2 · price: This transaction was executed in multiple trades at prices ranging from $71.26 to $71.87. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:53 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000052 · wf-form4_142299682673074.xml · derivative · entry 3 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,094 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:53 UTC |
Crowe Maria APresident, Mfg. Operations
|
Tax withholdingCommon Stock | 4,147 | $72.00 | $298,584.00 |
DisclosureSEC source: 0000059478-15-000052 · wf-form4_142299682673074.xml · nonDerivative · entry 2 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,745 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:53 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionCommon Stock | 9,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000052 · wf-form4_142299682673074.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:50 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Exercise / conversionRestricted Stock Unit · Derivative | 13,990 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000050 · wf-form4_142299663670511.xml · derivative · entry 4 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,990 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:50 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Tax withholdingCommon Stock | 6,608 | $72.00 | $475,776.00 |
DisclosureSEC source: 0000059478-15-000050 · wf-form4_142299663670511.xml · nonDerivative · entry 2 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,782 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:50 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Exercise / conversionCommon Stock | 13,990 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000050 · wf-form4_142299663670511.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:56 UTC |
Fry Stephen FSVP, HR & Diversity
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000054 · wf-form4_142299695397697.xml · derivative · entry 4 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,394 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:56 UTC |
Fry Stephen FSVP, HR & Diversity
|
Tax withholdingCommon Stock | 3,947 | $72.00 | $284,184.00 |
DisclosureSEC source: 0000059478-15-000054 · wf-form4_142299695397697.xml · nonDerivative · entry 2 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,610 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:56 UTC |
Fry Stephen FSVP, HR & Diversity
|
Exercise / conversionCommon Stock | 8,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000054 · wf-form4_142299695397697.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:58 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 52,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000056 · wf-form4_142299707583934.xml · derivative · entry 7 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,462 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:58 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 24,668 | $72.00 | $1,776,096.00 |
DisclosureSEC source: 0000059478-15-000056 · wf-form4_142299707583934.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,416 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:58 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 52,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000056 · wf-form4_142299707583934.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:59 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Exercise / conversionRestricted Stock Unit · Derivative | 20,985 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · derivative · entry 6 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,985 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:59 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Tax withholdingCommon Stock | 9,900 | $72.00 | $712,800.00 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,216 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:59 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Exercise / conversionCommon Stock | 20,985 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:01 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,591 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000060 · wf-form4_142299728909233.xml · derivative · entry 6 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,591 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:01 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Tax withholdingCommon Stock | 5,921 | $72.00 | $426,312.00 |
DisclosureSEC source: 0000059478-15-000060 · wf-form4_142299728909233.xml · nonDerivative · entry 2 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,487 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:01 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Exercise / conversionCommon Stock | 12,591 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000060 · wf-form4_142299728909233.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:04 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,995 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000062 · wf-form4_142299744578023.xml · derivative · entry 4 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,995 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:04 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Tax withholdingCommon Stock | 3,290 | $72.00 | $236,880.00 |
DisclosureSEC source: 0000059478-15-000062 · wf-form4_142299744578023.xml · nonDerivative · entry 2 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,405 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:04 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Exercise / conversionCommon Stock | 6,995 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000062 · wf-form4_142299744578023.xml · nonDerivative · entry 1 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:06 UTC |
Rice Derica WEVP-Global Services and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 26,581 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000064 · wf-form4_142299759301402.xml · derivative · entry 7 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,581 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:06 UTC |
Rice Derica WEVP-Global Services and CFO
|
Tax withholdingCommon Stock | 12,294 | $72.00 | $885,168.00 |
DisclosureSEC source: 0000059478-15-000064 · wf-form4_142299759301402.xml · nonDerivative · entry 2 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,445 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:06 UTC |
Rice Derica WEVP-Global Services and CFO
|
Exercise / conversionCommon Stock | 26,581 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000064 · wf-form4_142299759301402.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:08 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,591 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000066 · wf-form4_142299772208656.xml · derivative · entry 5 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,591 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:08 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Tax withholdingCommon Stock | 5,940 | $72.00 | $427,680.00 |
DisclosureSEC source: 0000059478-15-000066 · wf-form4_142299772208656.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,054 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.